Clinical trials generate enormous volumes of data. The integrity of that data — and the rigour of its analysis — is what regulators base approval decisions on. A single data quality failure can delay a submission by months. A poorly constructed statistical analysis plan can trigger an FDA information request on the eve of filing.
Clarus Research provides end-to-end clinical data management and biostatistics services designed specifically for the demands of pharmaceutical and biotech drug development. From database build through final locked datasets and statistical outputs, we deliver what your submission needs — on time and to the highest quality standards.
We design trial databases that are built right from the start — minimising data cleaning burden and downstream programming effort.
Regulatory submissions to FDA and EMEA increasingly require CDISC-compliant datasets. We build submission-ready data from the ground up.
Rigorous data cleaning is the backbone of a credible clinical submission. Our data managers apply systematic, protocol-driven review processes to every study dataset.
Sound statistical design is not an afterthought — it is the foundation of a credible clinical programme. Our biostatisticians engage early, at protocol development stage, to ensure your study is adequately powered and your analysis strategy will withstand regulatory review.
Our SAS and R programmers produce analysis outputs that are accurate, traceable, and submission-ready.
Whether you have a specific project in mind or know there are data or compliance gaps you need to address, our team can help you identify the right priorities. Schedule a free 30-minute discovery call and leave with a clearer picture of your next steps.
